share_log

華康生物醫學:有關收購目標公司19%股權及提供貸款之須予披露交易之補充公告

Huakang Biomedical Holdings: SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITION OF 19% EQUITY INTEREST OF THE TARGET COMPANY AND PROVISION OF LOAN

Feb 7, 2023 07:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more